Dissolved and financials
CVR: 39564432
Previous names: VaccImmune Europe IVS
Not available
Net result: DKK 17,538
No owners listed
CVR · view owners
No management registered
CVR · view management
Dissolved
Ceased 17 November 2021
CVR · view overview
0 employees
Annual report 2020 · average
Director role ended: Anders Rubinstein
CVR · 17/11/2021
View the full event history
VaccImmune Europe ApS was a Danish company of the type Anpartsselskab based in Nivå, founded in 2018. The company has been dissolved on 17 November 2021. The company was registered under the industry Forskning og eksperimentel udvikling indenfor bioteknologi. The company was previously named VaccImmune Europe IVS. According to the 2020 annual report, the company had an average of 0 employees. In 2020, the company reported a net result of DKK 17,538 compared with DKK -11,931 the year before. Equity in the 2020 report amounted to DKK 1.
Source: annual reports filed with the Danish Business Authority.
| Period | Revenue | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 202001/01/2020 – 31/12/2020 | - | 18 t. | 10 t. | 1 | 0 | |
| 201901/01/2019 – 31/12/2019 | - | -12 t. | 1 | -18 t. | 0 |
Screen owners and management against the Danish FSA's official PEP lists
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreNo. VaccImmune Europe ApS is registered in the Danish CVR register with the status Dissolved and ceased on 17 November 2021.
The CVR number of VaccImmune Europe ApS is 39564432.
VaccImmune Europe ApS had an average of 0 employees in the 2020 financial year according to the annual report.
VaccImmune Europe ApS was founded on 1 May 2018.
VaccImmune Europe ApS was registered under the industry Forskning og eksperimentel udvikling indenfor bioteknologi (industry code 721100).
VaccImmune Europe ApS was located at Gammel Strandvej 18, 2990 Nivå.
VaccImmune Europe ApS has published its annual report for 2020. The net result was DKK 17,538.
As of November 17, 2021, Anders Rubinstein has stepped down as liquidator of VaccImmune Europe ApS.
On November 17, 2021, VaccImmune Europe ApS exited liquidation.
VaccImmune Europe ApS was dissolved on November 17, 2021.
On October 13, 2021, the company changed its name from VaccImmune Europe IVS to VaccImmune Europe ApS.
As of September 24, 2021, Anders Rubinstein is registered as liquidator of VaccImmune Europe ApS.
On September 24, 2021, VaccImmune Europe ApS entered liquidation.
As of August 30, 2021, Anders Rubinstein has stepped down as liquidator of VaccImmune Europe ApS.
On August 30, 2021, VaccImmune Europe ApS exited liquidation.
VaccImmune Europe ApS has published its annual report for 2019. The net result was DKK -11,931.
As of July 15, 2020, Anders Rubinstein is registered as liquidator of VaccImmune Europe ApS.
As of July 15, 2020, Per Horn has stepped down as adm. dir. of VaccImmune Europe ApS.
On July 15, 2020, VaccImmune Europe ApS entered liquidation.
VaccImmune Europe ApS has published its interim report for the period May 1, 2018 to December 31, 2018.
As of March 6, 2019, Per Horn is registered as adm. dir. of VaccImmune Europe ApS.
As of March 6, 2019, Morten Albrechtsen has stepped down as adm. dir. of VaccImmune Europe ApS.
As of May 1, 2018, Morten Albrechtsen is registered as adm. dir. of VaccImmune Europe ApS.
VaccImmune Europe ApS was founded on May 1, 2018.
